The VaxSynergy initiative — Unlocking Innovation in Vaccine Development through a Collaborative Ecosystem
October 23, 2025 – Funded activities
News
Establishing a platform to innovate therapeutic vaccines using immunomodulatory nanoparticles
October 21, 2025 – Funded activities
Médicament Québec Funds Two Additional Structuring Activities in Vaccine Technologies
October 14, 2025 – News from Médicament Québec
Lipid Nanoparticle Platform with Active Endosomal Escape System to enhance RNA internalization for RNA vaccines
September 23, 2025 – Funded activities
Preclinical tools and services to decode B- and T-cell repertoires induced by immune responses in non-human primates
September 18, 2025 – Funded activities
Development of a New CHO Platform for the Manufacturing of Intranasal Influenza Vaccines
September 16, 2025 – Funded activities
Creation of a Québec Human Immunology Network to Support the Provincial Vaccine Ecosystem
September 11, 2025 – Funded activities
Médicament Québec Funds Four Innovative Vaccine Technology Initiatives
September 9, 2025 – News from Médicament Québec
A platform led by Professor Jörg Fritz of McGill University to stimulate the discovery and development of RNA vaccines
June 26, 2025 – Funded activities
Optimization and Scale-Up of RNA Therapeutics Through Next-Generation Manufacturing
June 23, 2025 – Funded Activities
UdeM’s Biopharmaceutical Unit: playing a key role in drug development
While the COVID-19 pandemic caused slowdowns in many fields, it underscored the importance of UdeM’s drug discovery units.
Artificial intelligence is driving research at the IRIC
At the second edition of the IRIC’s Rendez-vous Audace conference, Yoshua Bengio and Sébastien Lemieux explain how artificial intelligence is being used to advance cancer research.
Canada independence… in pharmaceuticals
The head of UdeM’s chemistry department thinks this nation can produce enough of its own prescription medications and not have to rely on imports in the fight against COVID-19.
Quebec gives UdeM $13 million to set up Médicament Québec
The Quebec government has awarded Université de Montréal $13 million to support the creation of Médicament Québec, an initiative that aims to revitalize the province’s pharmaceutical industry.